Literature DB >> 24226059

Serial cervicovaginal exposures with replication-deficient SIVsm induce higher dendritic cell (pDC) and CD4+ T-cell infiltrates not associated with prevention but a more severe SIVmac251 infection of rhesus macaques.

Shaheed A Abdulhaqq1, Melween I Martinez, Guobin Kang, Andrea S Foulkes, Idia V Rodriguez, Stephanie M Nichols, Meredith Hunter, Carlos A Sariol, Lynnette A Ruiz, Brian N Ross, Xiangfan Yin, David W Speicher, Ashley T Haase, Preston A Marx, Qinsheng Li, Edmundo N Kraiselburd, Luis J Montaner.   

Abstract

OBJECTIVE: Intravaginal exposure to simian immunodeficiency virus (SIV) acutely recruits interferon-alpha (IFN-α) producing plasmacytoid dendritic cells (pDC) and CD4 T-lymphocyte targets to the endocervix of nonhuman primates. We tested the impact of repeated cervicovaginal exposures to noninfectious, defective SIV particles over 72 hours on a subsequent cervicovaginal challenge with replication competent SIV.
METHODS: Thirty-four female Indian Rhesus macaques were given a 3-day twice-daily vaginal exposures to either SIVsmB7, a replication-deficient derivative of SIVsmH3 produced by a T lymphoblast CEMx174 cell clone (n = 16), or to CEM supernatant controls (n = 18). On the fourth day, animals were either euthanized to assess cervicovaginal immune cell infiltration or intravaginally challenged with SIVmac251. Challenged animals were tracked for plasma viral load and CD4 counts and euthanized at 42 days after infection.
RESULTS: At the time of challenge, macaques exposed to SIVsmB7, had higher levels of cervical CD123 pDCs (P = 0.032) and CD4 T cells (P = 0.036) than those exposed to CEM control. Vaginal tissues showed a significant increase in CD4 T-cell infiltrates (P = 0.048) and a trend toward increased CD68 cellular infiltrates. After challenge, 12 SIVsmB7-treated macaques showed 2.5-fold greater daily rate of CD4 decline (P = 0.0408), and viral load rise (P = 0.0036) as compared with 12 control animals.
CONCLUSIONS: Repeated nonproductive exposure to viral particles within a short daily time frame did not protect against infection despite pDC recruitment, resulting instead in an accelerated CD4 T-cell loss with an increased rate of viral replication.

Entities:  

Mesh:

Year:  2014        PMID: 24226059      PMCID: PMC3943721          DOI: 10.1097/QAI.0000000000000047

Source DB:  PubMed          Journal:  J Acquir Immune Defic Syndr        ISSN: 1525-4135            Impact factor:   3.731


  55 in total

1.  Late seroconversion in HIV-resistant Nairobi prostitutes despite pre-existing HIV-specific CD8+ responses.

Authors:  R Kaul; S L Rowland-Jones; J Kimani; T Dong; H B Yang; P Kiama; T Rostron; E Njagi; J J Bwayo; K S MacDonald; A J McMichael; F A Plummer
Journal:  J Clin Invest       Date:  2001-02       Impact factor: 14.808

2.  Absence of specific mucosal antibody responses in HIV-exposed uninfected sex workers from the Gambia.

Authors:  L Dorrell; A J Hessell; M Wang; H Whittle; S Sabally; S Rowland-Jones; D R Burton; P W Parren
Journal:  AIDS       Date:  2000-06-16       Impact factor: 4.177

3.  Innate NK cells and macrophages recognize and reject allogeneic nonself in vivo via different mechanisms.

Authors:  Wentao Liu; Xiang Xiao; Gulcin Demirci; Joren Madsen; Xian C Li
Journal:  J Immunol       Date:  2012-02-10       Impact factor: 5.422

4.  Cutting edge: progesterone regulates IFN-alpha production by plasmacytoid dendritic cells.

Authors:  Grant C Hughes; Sunil Thomas; Chang Li; Murali-Krishna Kaja; Edward A Clark
Journal:  J Immunol       Date:  2008-02-15       Impact factor: 5.422

5.  Innate sensing of HIV-infected cells.

Authors:  Alice Lepelley; Stéphanie Louis; Marion Sourisseau; Helen K W Law; Julien Pothlichet; Clémentine Schilte; Laurence Chaperot; Joël Plumas; Richard E Randall; Mustapha Si-Tahar; Fabrizio Mammano; Matthew L Albert; Olivier Schwartz
Journal:  PLoS Pathog       Date:  2011-02-17       Impact factor: 6.823

6.  Induction of APOBEC3 family proteins, a defensive maneuver underlying interferon-induced anti-HIV-1 activity.

Authors:  Gang Peng; Ke Jian Lei; Wenwen Jin; Teresa Greenwell-Wild; Sharon M Wahl
Journal:  J Exp Med       Date:  2006-01-17       Impact factor: 14.307

7.  Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection.

Authors:  Jesus F Salazar-Gonzalez; Maria G Salazar; Brandon F Keele; Gerald H Learn; Elena E Giorgi; Hui Li; Julie M Decker; Shuyi Wang; Joshua Baalwa; Matthias H Kraus; Nicholas F Parrish; Katharina S Shaw; M Brad Guffey; Katharine J Bar; Katie L Davis; Christina Ochsenbauer-Jambor; John C Kappes; Michael S Saag; Myron S Cohen; Joseph Mulenga; Cynthia A Derdeyn; Susan Allen; Eric Hunter; Martin Markowitz; Peter Hraber; Alan S Perelson; Tanmoy Bhattacharya; Barton F Haynes; Bette T Korber; Beatrice H Hahn; George M Shaw
Journal:  J Exp Med       Date:  2009-06-01       Impact factor: 14.307

8.  Immune correlates of aging in outdoor-housed captive rhesus macaques (Macaca mulatta).

Authors:  Elizabeth S Didier; Chie Sugimoto; Lisa C Bowers; Imtiaz A Khan; Marcelo J Kuroda
Journal:  Immun Ageing       Date:  2012-11-14       Impact factor: 6.400

9.  In captive rhesus macaques, cervicovaginal inflammation is common but not associated with the stable polymicrobial microbiome.

Authors:  Gregory Spear; Kristina Rothaeulser; Linda Fritts; Patrick M Gillevet; Christopher J Miller
Journal:  PLoS One       Date:  2012-12-28       Impact factor: 3.240

10.  Inflammatory genital infections mitigate a severe genetic bottleneck in heterosexual transmission of subtype A and C HIV-1.

Authors:  Richard E Haaland; Paulina A Hawkins; Jesus Salazar-Gonzalez; Amber Johnson; Amanda Tichacek; Etienne Karita; Olivier Manigart; Joseph Mulenga; Brandon F Keele; George M Shaw; Beatrice H Hahn; Susan A Allen; Cynthia A Derdeyn; Eric Hunter
Journal:  PLoS Pathog       Date:  2009-01-23       Impact factor: 6.823

View more
  6 in total

Review 1.  Friend or Foe: Innate Sensing of HIV in the Female Reproductive Tract.

Authors:  Nadia R Roan; Martin R Jakobsen
Journal:  Curr HIV/AIDS Rep       Date:  2016-02       Impact factor: 5.071

2.  Presence of CD8+ T cells in the ectocervical mucosa correlates with genital viral shedding in HIV-infected women despite a low prevalence of HIV RNA-expressing cells in the tissue.

Authors:  Anna Gibbs; Taha Hirbod; Qingsheng Li; Karin Bohman; Terry B Ball; Francis A Plummer; Rupert Kaul; Joshua Kimani; Kristina Broliden; Annelie Tjernlund
Journal:  J Immunol       Date:  2014-03-17       Impact factor: 5.422

3.  Short communication: Viremic control is independent of repeated low-dose SHIVSF162p3 exposures.

Authors:  Tara R Henning; Debra Hanson; Sundaram A Vishwanathan; Katherine Butler; Charles Dobard; Gerardo Garcia-Lerma; Jessica Radzio; James Smith; Janet M McNicholl; Ellen N Kersh
Journal:  AIDS Res Hum Retroviruses       Date:  2014-10-14       Impact factor: 2.205

4.  Tenofovir alafenamide and elvitegravir loaded nanoparticles for long-acting prevention of HIV-1 vaginal transmission.

Authors:  Subhra Mandal; Pavan K Prathipati; Guobin Kang; You Zhou; Zhe Yuan; Wenjin Fan; Qingsheng Li; Christopher J Destache
Journal:  AIDS       Date:  2017-02-20       Impact factor: 4.177

5.  Topical Tenofovir Disoproxil Fumarate Nanoparticles Prevent HIV-1 Vaginal Transmission in a Humanized Mouse Model.

Authors:  Christopher J Destache; Subhra Mandal; Zhe Yuan; Guobin Kang; Abhijit A Date; Wuxun Lu; Annemarie Shibata; Rachel Pham; Patrick Bruck; Michael Rezich; You Zhou; Renuga Vivekanandan; Courtney V Fletcher; Qingsheng Li
Journal:  Antimicrob Agents Chemother       Date:  2016-05-23       Impact factor: 5.191

6.  HIV-1-negative female sex workers sustain high cervical IFNɛ, low immune activation, and low expression of HIV-1-required host genes.

Authors:  S A Abdulhaqq; C Zorrilla; G Kang; X Yin; V Tamayo; K E Seaton; J Joseph; S Garced; G D Tomaras; K A Linn; A S Foulkes; L Azzoni; M VerMilyea; C Coutifaris; A V Kossenkov; L Showe; E N Kraiselburd; Q Li; L J Montaner
Journal:  Mucosal Immunol       Date:  2015-11-11       Impact factor: 7.313

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.